Inflammatory bowel disease and Parkinson's disease: common pathophysiological links

被引:107
|
作者
Lee, Ho-Su [1 ,2 ]
Lobbestael, Evy [3 ]
Vermeire, Severine [4 ,5 ]
Sabino, Joao [4 ,5 ]
Cleynen, Isabelle [1 ]
机构
[1] Katholieke Univ Leuven, Dept Human Genet, B-3000 Leuven, Belgium
[2] Univ Ulsan, Dept Biochem & Mol Biol, Coll Med, Seoul, South Korea
[3] Katholieke Univ Leuven, Lab Neurobiol & Gene Therapy, Leuven, Belgium
[4] Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing, Leuven, Belgium
[5] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium
基金
新加坡国家研究基金会;
关键词
ALPHA-SYNUCLEIN; GUT MICROBIOTA; LRRK2; G2019S; RISK; ASSOCIATION; STRESS; DEGRADATION; DYSFUNCTION; IMPAIRMENT; PREVALENCE;
D O I
10.1136/gutjnl-2020-322429
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Inflammatory bowel disease and Parkinson's disease are chronic progressive disorders that mainly affect different organs: the gut and brain, respectively. Accumulating evidence has suggested a bidirectional link between gastrointestinal inflammation and neurodegeneration, in accordance with the concept of the 'gut-brain axis'. Moreover, recent population-based studies have shown that inflammatory bowel disease might increase the risk of Parkinson's disease. Although the precise mechanisms underlying gut-brain interactions remain elusive, some of the latest findings have begun to explain the link. Several genetic loci are shared between both disorders with a similar direction of effect on the risk of both diseases. The most interesting example is LRRK2 (leucine-rich repeat kinase 2), initially identified as a causal gene in Parkinson's disease, and recently also implicated in Crohn's disease. In this review, we highlight recent findings on the link between these seemingly unrelated diseases with shared genetic susceptibility. We discuss supporting and conflicting data obtained from epidemiological and genetic studies along with remaining questions and concerns. In addition, we discuss possible biological links including the gut-brain axis, microbiota, autoimmunity, mitochondrial function and autophagy.
引用
收藏
页码:408 / 417
页数:10
相关论文
共 50 条
  • [41] Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease?
    Mary K. Herrick
    Malú G. Tansey
    npj Parkinson's Disease, 7
  • [42] The risk of Parkinson's disease in inflammatory bowel disease: A systematic review and meta-analysis
    Zhu, Feng
    Li, Chuling
    Gong, Jianfeng
    Zhu, Weiming
    Gu, Lili
    Li, Ning
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (01) : 38 - 42
  • [43] Lack of Causal Associations of Inflammatory Bowel Disease with Parkinson's Disease and Other Neurodegenerative Disorders
    Zeng, Ruijie
    Wang, Jinghua
    Zheng, Chunwen
    Jiang, Rui
    Tong, Shuangshuang
    Wu, Huihuan
    Zhuo, Zewei
    Yang, Qi
    Leung, Felix W.
    Sha, Weihong
    Chen, Hao
    MOVEMENT DISORDERS, 2023, 38 (06) : 1082 - 1088
  • [44] Association between inflammatory bowel disease and Parkinson's disease: seek and you shall find?
    Weimers, Petra
    Halfvarson, Jonas
    Sachs, Michael C.
    Ludvigsson, Jonas F.
    Peter, Inga
    Olen, Ola
    Burisch, Johan
    GUT, 2019, 68 (01) : 175 - +
  • [45] Cardiovascular disease and Alzheimer's disease: common links
    Stampfer, M. J.
    JOURNAL OF INTERNAL MEDICINE, 2006, 260 (03) : 211 - 223
  • [46] Behcet's disease and inflammatory bowel disease
    Takeno, M
    Ishigatsubo, Y
    INTERNAL MEDICINE, 2004, 43 (03) : 172 - 173
  • [47] Common Pitfalls in Management of Inflammatory Bowel Disease
    Pasumarthy, Lakshmi
    Srour, James
    Choudhary, Cuckoo
    GASTROENTEROLOGY RESEARCH, 2009, 2 (04) : 200 - 208
  • [48] Common links between metabolic syndrome and inflammatory bowel disease: Current overview and future perspectives
    Michalak, Arkadiusz
    Mosinska, Paula
    Fichna, Jakub
    PHARMACOLOGICAL REPORTS, 2016, 68 (04) : 837 - 846
  • [49] Common links between metabolic syndrome and inflammatory bowel disease: Current overview and future perspectives
    Arkadiusz Michalak
    Paula Mosińska
    Jakub Fichna
    Pharmacological Reports, 2016, 68 : 837 - 846
  • [50] Inflammatory bowel disease, immunosuppressant use, and lower risk of Parkinson Disease
    Camacho-Soto, A.
    Nielsen, S. Searles
    Racette, B. A.
    MOVEMENT DISORDERS, 2017, 32 (09) : E5 - E5